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Background: Cyperus rotundus Linn. (Cyperaceae) is used to treat inflammation, pain, fever, wounds, boils and
blisters in folk medicine. This study evaluated the antinociceptive effect of the hydromethanol extract of whole
plant of C. rotundus (HMCR).
Methods: The antinociceptive activity of HMCR was investigated in thermal-induced (hot plate and tail immersion)
and chemical-induced (formalin) nociception models in mice at three different doses (50, 100 and 200 mg/kg; p.o.).
Morphine sulphate (5 mg/kg, i.p.) and diclofenac sodium (10 mg/kg, i.p.) were used as reference analgesic agents.
Results: In the hot-plate and tail-immersion tests HMCR significantly increased the latency period to the thermal
stimuli at all the tested doses (50, 100 and 200 mg/kg) (p < 0.05). The significant increase in latency is clear from the
observations at 60 and 90 min. In formalin-induced paw licking test oral administration of HMCR at 100 and
200 mg/kg doses decreased the licking of paw in early phase. All the tested doses (50, 100 and 200 mg/kg)
significantly decreased the licking of paw in late phase of the test (p < 0.001). The dose 200 mg/kg was most
effective showing maximum percentage of inhibition of licking in both early (61.60%) and late phase (87.41%).
Conclusion: These results indicate the antinociceptive effect of C. rotundus and suggest that this effect is mediated
by both peripheral and central mechanisms. These results support the traditional use of this plant in different
painful conditions.
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The genus Cyperus includes common weeds found mainly
in upland, paddy fields as well as marshy places in tropical,
subtropical and temperate regions. Cyperus rotundus
Linn., commonly known as nutgrass, is a perennial, her-
baceous sedge with scaly creeping rhizomes and bulbous
at the base. It is locally known as “Mutha”. The plant is a
widely used traditional medicinal herb in India, China,
Japan, Korea, Combodia, Nigeria, and Bangladesh. Mainly
the rhizomatous tubers are used in stomach and bowel
disorders, inflammatory diseases [1,2], as an analgesic, a
sedative drug [1] etc. Besides many other uses, this plant
is used in different painful conditions such as inflamma-
tion, pain, fever, wounds, boils and blisters [3]. Different* Correspondence: zafarimam@gmail.com
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article, unless otherwise stated.chemical compounds such as alkaloids, flavonoids, tan-
nins, starch, glycosides, furochromones, monoterpenes,
sesquiterpenes, sitosterol, essential oil, fatty oil containing
a neutral waxy substance, glycerol, linolenic, myristic and
stearic acids and many other compounds have been iso-
lated from the plant [3,4]. Pharmacological properties
such as anti-candida [5], anti-inflammatory [6], antidia-
betic [7], antidiarrhoeal [8,9], cytoprotective [10], antimu-
tagenic [11], antimicrobial, antioxidant [12], antibacterial,
cytotoxic and apoptotic [13,14], analgesic [15], anticonvul-
sant [16], and wound healing [17] activities have been
reported.
The use of C. rotundus in different painful conditions in
folk medicine but lack of scientific study reporting its anti-
nociceptive activity in both chemical- and heat-induced
nociception models convinced us to design the presenttral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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methanol extract of the whole plant of C. rotundus.
Methods
Plant materials and extract preparation
The whole plant of C. rotundus Linn. was collected from
Manikgonj district of Bangladesh in October, 2012. The
collected plants were then identified by the experts of
National Herbarium, Mirpur, Dhaka, Bangladesh (Accession
No. 37861) where a voucher specimen has been deposited
for further reference. The whole plant samples were
washed, dried, grounded and 250 g of the dried powder
was taken in a beaker. Then methanol and water (70:30)
was added at the amount of 840 ml and 360 ml respec-
tively and it was kept for three days with occasional stir-
ring. Then it was filtered using a sterilized cotton filter
and dried using rotary evaporator. After drying, 21.9 g
(yield 8.76%) of dried extract was obtained from 250 g of
powder. This crude extract was used for the investigation.
Chemicals
Diclofenac sodium (Square Pharmaceuticals Ltd., Bangladesh),
Morphine sulphate (Gonoshasthaya Pharmaceuticals
Ltd., Bangladesh), 0.9% Sodium chloride solution (Nor-
mal saline) (Orion Infusion Ltd., Bangladesh), Formalin
(Merck, Germany) and other reagents were of analytical
grade.
Animals
Swiss Albino mice (20-25 g) were collected from the Ani-
mal Resources Branch of the International Center for Diar-
rhoeal Disease Research, Bangladesh (ICDDR,B). Animals
were housed in cages and were maintained under stan-
dard environmental conditions (Temperature: 24.0 ± 1.0°C;
relative humidity: 55-65%; 12 hrs light/12 hrs dark cycle).
Pellets of mice food prepared by ICDDR,B were given to
the mice with fresh water ad libitum. All the experimental
animals were treated following the Ethical Principles and
Guidelines for Scientific Experiments on Animals (1995)
formulated by The Swiss Academy of Medical Sciences and
the Swiss Academy of Sciences. The study protocol was
approved by the Ethics Committee of Stamford University
Bangladesh.
Acute toxicity test
Mice were divided into control and four test groups (n = 5).
The test groups received HMCR orally at the doses of
1000, 1500, 2000, and 3000 mg/kg body weight. After
gavage the animals were kept in separate cages and were
allowed to food and water ad libitum. The animals were
then observed for possible behavioral changes, allergic
reactions (skin rash, itching) and mortality for the next
72 h [18].Hot plate test
The hot-plate test was performed according to the method
described by Eddy and Leimbach (1953) [19] with slight
modification. The temperature of the metal surface of
Eddy’s hotplate was set at 52 ± 2°C. The mice that showed
fore paw licking, withdrawal of the paw(s) or jumping re-
sponse within 15 s on hotplate were selected for this study
24 h prior to the experiment. Mice were fasted overnight
with water given ad libitum. The mice were then treated
with 0.9% sodium chloride solution as vehicle (0.1 ml/
mice, p.o.), HMCR (50, 100, and 200 mg/kg), and mor-
phine as positive control (5 mg/kg, i.p.). HMCR was ad-
ministered (50, 100 and 200 mg/kg, p.o.) 30 min before
the experiment while morphine sulphate was administered
(5 mg/kg, i.p.) 15 min before the experiment. The re-
sponse in the form of fore paw licking, withdrawal of the
paw(s) or jumping was recorded at 30, 60, 90, and
120 min following treatment. A cut off period of 20 s was
maintained to avoid paw tissue damage. The results of the
hot plate test are expressed as a percentage of the max-
imal possible effect (%MPE), which was calculated using
following formula:
%MPE ¼ ½ Postdrug latency−predrug latencyð Þ
= Cut off period−predrug latencyð Þ  100:
Tail immersion test
This test is based on the observation that morphine like
drugs selectively prolongs the reaction time of the typi-
cal tail-withdrawal reflex in mice [20,21]. HMCR was ad-
ministered (50, 100 and 200 mg/kg, p.o.) 30 min before
the experiment and morphine sulphate was administered
(5 mg/kg, i.p.) 15 min before the experiment. 1 to 2 cm
of the tail of mice was immersed in warm water kept
constant at 52 ± 1°C. The reaction time was the time
taken by the mice to deflect the tail. The latency period
of the tail-withdrawal response was taken as the index of
antinociception and was determined at 30, 60, 90, and
120 min after the treatments. To determine the baseline,
each animal was tested before administration of drug/ex-
tract. The %MPE was calculated using the same formula
used in hot plate test.
Formalin-induced paw licking test
Formalin-induced paw licking test was performed as de-
scribe by Santos and Calixto [22] and Santos et al. [23].
20 μL of 2.5% formalin solution (0.92% of formaldehyde),
made up in saline water, was injected into the sub-plantar
area of the right hind paw of mice. Animals were pre-
treated with different doses of HMCR (50, 100 and
200 mg/kg, p.o.) 60 min before formalin injection. Control
group received only the vehicle (0.1 ml/kg saline water).
Mice treated with morphine (5 mg/kg, i.p.) 15 min before
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Licking of the injected paw was counted from 0-5 min
(first phase) and 15-30 min (second phase) after formalin
injection, corresponding to the neurogenic and inflamma-
tory pain responses, respectively. The initial response was
initially attributed to a direct algogenic effect of formalin
on the nociceptors whereas phase two was associated with
the release of local endogenous mediators responsible for
sensitization of primary and spinal sensory neurons and
subsequent activation of the nociceptors [24].
Statistical analysis
The results are presented as Mean ± SEM. The one-way
ANOVA test with Dunnett’s post hoc test was used to
analyze the data using SPSS 11.5 software. p < 0.05-0.001
were considered as statistically significant.
Results and discussion
Acute toxicity
Administration of HMCR at the doses 1000, 1500, 2000
and 3000 mg/kg did not cause any mortality, behavioral
changes, or allergic reactions. So it can be said that LD50
of C. rotundus is more than 3000 mg/kg and therefore it
showed low toxicity profile.
Hot plate test
Table 1 shows the antinociceptive effect of HMCR and
standard drug (Morphine) assessed using the hot plate
test. HMCR, at the doses of 100 and 200 mg/kg, exhibited
significant (p < 0.001) ability to prolong the latency of
response to thermal-induced nociception throughout the
whole experimental period. The effect was dose-dependent
and HMCR showed stronger effect at 100 and 200 mg/kg
doses. The extract showed significant %MPE at 50, 100
and 200 mg/kg doses.
The hot-plate test is a specific test carried out to verify in-
volvement of central mechanism with compounds/drugs
showing antinociceptive activity [25]. In this work, HMCR
showed a marked inhibition on thermal‐induced hyperal-
gesia as it showed significant increase in latency (p < 0.001)
compared to control. Morphine (5 mg/kg i.p.) was used asTable 1 Antinociceptive effect of C. rotundus extract and mor
Treatment Dose
(mg/kg) Pretreatment 30 min
Vehicle 0.1 ml/mice 7.44 ± 0.48 7.89 ± 0.62
Morphine sulphate 5 8.70 ± 0.72 14.89 ± 1.01**(54.7
HMCR 50 8.22 ± 0.91 10.27 ± 0.55(17.45
HMCR 100 6.19 ± 0.91 10.11 ± 0.72(28.38
HMCR 200 8.22 ± 0.72 12.21 ± 0.62*(33.89
Each value is presented as the mean ± SEM (n = 5); *p < 0.05 compared with the con
(Dunnett’s test).a standard drug which demonstrated a stronger analgesic
effect than HMCR. The effect was evident from the elong-
ation of the latency time till the 3rd observation (90 min).
The effect of compounds or plant extract in such mecha-
nism by increasing the latency are suggested to act like
centrally mediated drugs [26] by activating the periaque-
ductal gray matter (PAG) to release endogenous peptides
(i.e., endorphin or enkephalin). These endogenous pep-
tides descend the spinal cord and function as inhibitors of
the pain impulse transmission at the synapse in the dorsal
horn [27].
Tail immersion test
The tail-withdrawal reflex time of the mice to the hot
water-induced pain was also significant after administration
of HMCR (Table 2). The effect of HMCR at 100 and
200 mg/kg doses at 60 and 90 min was significant (p < 0.05)
in comparison to control while at dose 50 mg/kg it did
not show any significant increase in latency. The maxi-
mum effect of the extract was recorded at 60 min. How-
ever, the increase in latency was less significant than that
observed in the hot plate test. Morphine at 5 mg/kg
showed highest %MPE values while the extract also
showed significant %MPE at 100 and 200 mg/kg doses
(p < 0.05) at different observation time.
Tail immersion model is considered as an acute pain
model. The tail-withdrawal response of mice is predomi-
nantly considered to be selective for centrally acting anal-
gesics, whereas the peripherally acting drugs are known to
be inactive on such heat-induced pain response [28]. The
significant increase (p < 0.05) in tail-withdrawal time by
the extract suggests the involvement of central mecha-
nisms in its antinociceptive effect. Both tail immersion
and hot plate test measure the latency time of mice to
thermal stimuli. Tail immersion monitors a spinal reflex
involving μ2- and δ-opioid receptors, whereas the hot
plate demonstrates supraspinal reflex mediated by μ1- and
μ2-opioid receptors [29]. Therefore, the results of the
present study indicate that the central antinociceptive ef-
fect of C. rotundus may be prominent on μ-opioid
receptors.phine in hot plate test
Response time (s) (%MPE)
60 min 90 min 120 min
7.52 ± 0.86 7.91 ± 0.90 8.44 ± 0.83
2) 18.17 ± 0.66**(83.76) 14.70 ± 0.26**(53.04) 12.99 ± 0.93(37.94)
) 11.97 ± 0.28*(31.89) 10.85 ± 0.90(22.35) 9.22 ± 1.32(8.52)
) 13.03 ± 1.18**(49.55) 11.63 ± 0.97*(39.43) 10.77 ± 0.83(33.17)
) 13.93 ± 0.63**(48.51) 11.99 ± 0.76*(32.04) 11.07 ± 1.47(24.19)
trol group (Dunnett’s test). **p < 0.001 compared with the control group
Table 2 Antinociceptive effect of C. rotundus extract and morphine in tail immersion test
Treatment Dose
(mg/kg)
Response time (s) (%MPE)
Pretreatment 30 min 60 min 90 min 120 min
Vehicle 0.1 ml/mice 2.83 ± 0.48 2.62 ± 0.37 2.68 ± 0.46 2.66 ± 0.43 2.59 ± 0.48
Morphine sulphate 5 2.66 ± 0.56 5.42 ± 0.47**(37.62) 6.21 ± 0.41**(48.32) 4.64 ± 0.31*(26.00) 3.57 ± 0.40(12.45)
HMCR 50 2.31 ± 0.37 3.25 ± 0.47(12.22) 3.98 ± 0.17(21.71) 3.14 ± 0.12(10.87) 2.62 ± 0.24(4.03)
HMCR 100 2.66 ± 0.12 3.66 ± 0.35(13.61) 4.52 ± 0.32*(25.33) 3.88 ± 0.34*(16.61) 2.97 ± 0.17(4.30)
HMCR 200 2.54 ± 0.49 3.87 ± 0.35(17.88) 4.44 ± 0.36*(25.47) 4.16 ± 0.34*(21.66) 3.14 ± 0.24(8.04)
Each value is presented as the mean ± SEM (n = 5); *p < 0.05 compared with the control group (Dunnett’s test), **p < 0.001 compared with the control group
(Dunnett’s test).
Imam and Sumi BMC Complementary and Alternative Medicine 2014, 14:83 Page 4 of 5
http://www.biomedcentral.com/1472-6882/14/83Formalin-induced paw licking test
HMCR has shown a dose-dependent antinociceptive
effect in both phases of Formalin test. HMCR (50, 100
and 200 mg/kg p.o.) significantly (p < 0.001) reduced the
number of paw licking in both phases of the test when
compared to control group. Morphine and diclofenac
sodium, used as positive control decreased the lic-
king significantly compared to control in both phases
(Table 3).
In formalin-induced paw licking test HMCR has
shown the ability to affect both the early and late phase
inflammatory effects of the formalin test, which implies
the involvement of not only the central mechanism but
also the peripheral antinociceptive activity of the extract.
The early phase, classified as neurogenic pain, is an
acute response observed immediately after the adminis-
tration of formalin and is due to direct action of injected
formalin on nociceptors. While the late phase, classified
as an inflammatory pain, is a late response resulting
from the inflammatory processes generated by the re-
lease of inflammatory mediators such as histamine, sero-
tonin, prostaglandins and bradykinin, and activation of
the neurons in the dorsal horns of the spinal cord [30].
Both phases have their own characteristics that can be
used as tool to assess the antinociceptive potential as
well as to elucidate the mechanisms of antinociception.
The early phase represents a direct irritant effect ofTable 3 Antinociceptive effect of C. rotundus extract, morphin
test
Treatment Dose
(mg/kg) Early phase (0-5 min)
Vehicle 0.1 ml/mice 157.00 ± 8.21
Morphine sulphate 5 44.20 ± 5.44*
Diclofenac sodium 10 89.60 ± 7.41*
HMCR 50 135.20 ± 7.12
HMCR 100 89.40 ± 6.88*
HMCR 200 60.60 ± 9.32*
Each value is presented as the mean ± SEM (n = 5); *p < 0.001 compared with the coformalin on sensory fibers, while the late phase repre-
sents response secondary to the development of inflam-
matory process and the release of inflammatory
mediators [31]. It has been reported that drugs acting
centrally (i.e. narcotics/opioids) inhibit both phases of
the formalin test while those acting peripherally (i.e.
NSAIDs) inhibit only the late phase, respectively [32,33].
Therefore, the results shown by HMCR suggest that the
extract contains bioactive compound(s) with central and
peripheral antinociceptive actions and additional anti-
inflammatory activity [30]. The ability of HMCR to in-
hibit chemically- and thermally-induced nociceptive pro-
cesses tested in this study presents its potential to be
used as an analgesic agent.
Conclusion
Results of the present study indicate that all tested doses of
HMCR exhibited significant central and peripheral antino-
ciceptive effect. The effect is rapid, long lasting, and statisti-
cally significant particularly at 100 and 200 mg/kg doses.
Taking these findings into account, it seems quite possible
that C. rotundus contains constituents with promising anti-
nociceptive activity. The traditional use of the plant in the
treatment of painful conditions can be affirmed by this
study. However, further studies are required to isolate the
bioactive compounds and elucidate the precise mechanisms
responsible for the antinociceptive activity.e and diclofenac sodium in formalin-induced paw licking
Number of licking
% inhibition Late phase (15-30 min) % inhibition
- 189.00 ± 6.42 -
71.99 8.40 ± 1.81* 95.56
43.22 35.40 ± 2.86* 81.27
14.32 90.80 ± 8.64* 51.96
43.35 51.40 ± 9.47* 72.80
61.60 23.80 ± 5.08* 87.41
ntrol group (Dunnett’s test).
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